Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 10, 2023

SELL
$41.91 - $50.48 $1,131 - $1,362
-27 Reduced 8.65%
285 $14,000
Q3 2022

Nov 08, 2022

SELL
$40.9 - $50.42 $1,022 - $1,260
-25 Reduced 7.42%
312 $13,000
Q2 2022

Aug 05, 2022

BUY
$42.98 - $49.77 $1,160 - $1,343
27 Added 8.71%
337 $16,000
Q1 2022

May 13, 2022

BUY
$42.23 - $54.3 $84 - $108
2 Added 0.65%
310 $15,000
Q4 2021

Feb 11, 2022

BUY
$50.62 - $56.47 $1,164 - $1,298
23 Added 8.07%
308 $17,000
Q2 2021

Aug 11, 2021

SELL
$46.28 - $52.75 $694 - $791
-15 Reduced 5.0%
285 $14,000
Q1 2021

May 13, 2021

SELL
$46.25 - $56.02 $3,607 - $4,369
-78 Reduced 20.63%
300 $15,000
Q4 2020

Feb 12, 2021

SELL
$46.09 - $54.74 $645 - $766
-14 Reduced 3.57%
378 $20,000
Q2 2020

Aug 13, 2020

SELL
$39.49 - $44.36 $197 - $221
-5 Reduced 1.26%
392 $17,000
Q4 2019

Feb 14, 2020

SELL
$25.41 - $43.1 $609 - $1,034
-24 Reduced 5.7%
397 $13,000
Q2 2019

Jul 09, 2019

SELL
$35.73 - $41.39 $4,609 - $5,339
-129 Reduced 23.45%
421 $17,000
Q1 2019

May 10, 2019

BUY
$33.78 - $40.68 $810 - $976
24 Added 4.56%
550 $22,000
Q4 2018

Feb 13, 2019

BUY
$32.65 - $37.95 $17,173 - $19,961
526 New
526 $18,000

Others Institutions Holding QGEN

About QIAGEN N.V.


  • Ticker QGEN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 227,694,000
  • Market Cap $9.16B
  • Description
  • QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacteria...
More about QGEN
Track This Portfolio

Track Zions Bancorporation, N.A. Portfolio

Follow Zions Bancorporation, N.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zions Bancorporation, N.A., based on Form 13F filings with the SEC.

News

Stay updated on Zions Bancorporation, N.A. with notifications on news.